Nanovis licenses key nanosurface technology patent from the University of Nevada, Reno
This foundational nanotechnology patent, covering the use of ceramics on spinal implants with nanopores, builds on Nanovis’ superior portfolio of fixation technologies.
CARMEL, Indiana. – Sept. 11, 2018 – Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the University of Nevada, Reno for a key nanosurface technology patent covering the use of ceramics on implants with nanopores.
This foundational patent allows development of ceramics for medical implants with nanosurfacing that enhances cell binding and drug delivery depending on the purpose of implantation.
The ceramic nanosurfacing technology dovetails with Nanovis’ technology, offering a range of spinal implant nanosurfaces designed to increase bone to implant growth. The addition of ceramic nanosurfacing allows Nanovis to extend its lead in the development of superior fixation technology for medical implants with greater strength, osseointegration and bactericidal properties.
“We are delighted to work with the University of Nevada, Reno on this nanotechnology,” says Matt Hedrick, Nanovis CEO. “Adding ceramics to nanopores provides important capabilities to influence cells attaching to the surface and for drug delivery. This technology used in combination with our nanotube surface will further bolster our portfolio of interbodies, screws and other implants as the superior fixation technology choice for surgeons to heal their patients and distributors to grow their business.”
The company’s technology already offers interbodies with the best combination of deeply porous bone interface scaffold and bridging bone visualization with a nanotube surface. Adding nanoscale ceramic technology further advances Nanovis’ surface technology lead and extends the company’s portfolio of implant offering the superior fixation technology choice.
“We can control the length, the height, the pore openings and the pore volumes within the ceramic nanosurface,” says Mano Misra, professor of materials science and engineering at the University of Nevada, Reno. “The sizes and shapes of the nanosurface pores can be changed so the ceramic coating releases drugs over a longer period of time, providing superior anti-infection properties.”
“Bringing discoveries into the marketplace is the way that university research benefits society,” says Ellen Purpus, University of Nevada, Reno assistant vice president for Enterprise & Innovation.
For more information about how to help patients, or better serve surgeons with Nanovis’ nanotechnologies, please visit us during the North American Spine Society (NASS) 2018 meeting September 26-29 in Los Angeles at Booth #2260 or call 1-317-507-1058.
For more information about distribution opportunities, please contact Jeff Shepherd, Vice President of Sales, at
About Nanovis
Nanovis LLC’s vision is to become a high growth company using nanotechnology to enhance the performance of its surgical implants. The company’s broad intellectual property portfolio can be used to enhance implants to better manage the interface with bone, soft tissue, nerves, cardiovascular tissue, and to reduce colonization of implants by bacteria. For more information about Nanovis, visit www.nanovisinc.com or call Nanovis at 1-877-907-NANO.
Connect With Us
Columbia City, IN 46725
United States
Recent News